GHK-Cu and sourcing and quality: what actually matters

Someone on r/Peptides posted a photo of their GHK-Cu vial and one question: is this legit or fake? That question comes up constantly because GHK-Cu is one of the most counterfeited and most poorly sourced peptides on the market, and almost nobody explains what actually separates a real vial from a bad one beyond "check if it's blue." Short answer: color is a hint, not a verdict, and GHK-Cu sourcing and quality come down to three things you can actually check, a certificate of analysis, storage history, and vendor transparency, none of which require a chemistry degree.

Why color alone doesn't settle it

GHK-Cu is glycyl-L-histidyl-L-lysine bound to a copper ion, and that copper is genuinely why a correctly made batch looks a deep, almost electric blue. I get why people lean on that. It's the one thing you can check with your eyes before you've spent a dollar. But blue is a property of copper complexes generally, not of this specific tripeptide, and a manufacturer cutting corners can produce something blue that has little or none of the actual peptide in it. I've had clients send me photos of gorgeous blue vials that turned out, once tested, to be underdosed by half. The color told them nothing about what was actually inside.

The reverse matters too: a vial that arrives lighter than expected or has gone slightly translucent isn't automatically fake. Copper can fall out of the coordination complex over time, especially with heat or light exposure, and a genuine peptide that has degraded in transit can look off without ever having been counterfeit. So color works as a first filter, not a final answer. If a vendor tells you "it's blue, that's how you know it's real," that is not a company that has thought hard about how they'd actually prove it to you.

What actually proves what's in the vial

The proof is a third-party certificate of analysis, run by a lab that has no financial stake in the result, using HPLC to measure concentration and mass spectrometry to confirm identity, the same combination of methods that established the coordination chemistry of the GHK-copper complex in the first place. HPLC tells you how much of the peptide is actually in the solution. Mass spec tells you the molecule in the vial is GHK-Cu and not a mislabeled substitute or a partial degradation product. A batch-specific COA is the only document that ties both of those results to the exact lot number printed on your vial, not to some other batch the company tested once and now reuses on every listing.

Ask for that COA before you buy, not after you're worried. If a seller can't produce one, or hands you a COA for a lot number that doesn't match what shipped, that's your answer regardless of how the liquid looks. I tell every client the same thing I'd want told to me: a company that has real testing discipline wants to show it off, because it's their best sales argument. A company that dodges the question usually has a reason to.

The mechanism reason GHK-Cu is worth getting right in the first place is also worth knowing, because it explains why a poorly made batch isn't just "a little weaker." Free copper is chemically reckless. It cycles between oxidation states and catalyzes the formation of reactive molecules that damage DNA and cell membranes, which is why your body never lets copper travel unescorted. GHK is one of the molecules that chaperones it safely, folding around the copper ion in a specific structure that only releases it once it's inside the cell that needs it. A degraded or badly synthesized batch can leave copper unbound, which means you're not getting a chaperoned delivery system anymore, you're getting the raw ingredient the chaperone exists to control.

Storage and handling: the part people skip

Even a genuinely well-made vial can turn into a weak one before it ever reaches your syringe. The real degradation drivers for a peptide like this are heat, time sitting reconstituted in solution, light exposure, and oxidation. A vial that sat in a hot delivery van for three days, or that gets left out on a bathroom counter under a window, is losing potency the whole time regardless of how it was made. Shaking or normal handling is not on that list. That myth gets repeated constantly in peptide forums and it's simply not how these small peptides break down.

Practically, that means: keep the lyophilized powder refrigerated or frozen until you reconstitute it, keep the reconstituted vial refrigerated and use it within the window most vendors specify, and keep it out of direct light. If a seller ships peptides in unrefrigerated packaging with no ice pack in warm weather, that's a sourcing red flag even if the underlying product started out clean. I've seen people blame a peptide for "not working" when the real problem was a week in a hot mailbox.

One honest caveat that belongs here: there is no injectable human trial of GHK-Cu at any dose, for any indication, so everything above about how the compound behaves once injected rests on animal studies, mechanistic chemistry, and practitioner experience, not on human trial data specific to the injectable route. The topical cosmetic form has the deepest human evidence, and it's a reasonable starting point if skin is your actual goal. If the goal is the systemic remodeling effect people describe with the injectable form, know you're standing on a mechanistic and animal case rather than a human trial. Second, fibroblasts respond to GHK by producing more collagen, elastin, and glycosaminoglycans in animal wound models, and that signaling effect is specific to the correct sequence, a scrambled control peptide does nothing. That specificity is exactly why sourcing matters: a peptide with even a small structural error isn't a weaker version of GHK-Cu, it may not be doing the job at all.

Now the part my lawyer makes me say, and he's right: the doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

The community-standard injectable dose most people run is 1 to 3 mg per day, subcutaneous, typically in the morning, cycled 8 to 12 weeks on with time off rather than continuous. That's the real-world number the practitioner and user community has converged on, extrapolated from the animal dosing work referenced above, not from a human injectable trial. Whatever dose you land on, it only means anything if the vial you're dosing from is what the label claims.

If you want the deeper mechanism and evidence breakdown, including where the age-related decline in GHK levels comes from, I go through it in the full GHK-Cu entry, and the GHK free-base form is worth understanding separately since it's the parent molecule the copper-bound version is built from. For the mechanics of reading a COA line by line, the certificate-of-analysis guide walks through exactly what a real one looks like versus a decorative one.

Heads up: OHM has an affiliate relationship with the vendors linked on this site, so we earn a commission if you buy through one of those links. It costs you nothing extra and it doesn't change which peptide the evidence supports, I only link vendors I'd actually recommend to a client asking me the same question that Reddit thread asked.

Thanks for reading! In health, Rick Gold